Physician profile
Karina Condez
NPI 1760968846
$5,374.62
in general payments reported to CMS, 2019-2025
12 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $2,629 · 2023: $628 · 2024: $1,183 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,369.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $2,187.25 | 2022 | |
| Innovation Technologies INC | $547.42 | 2024 | Irrisept |
| Axogen | $490.89 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Davol INC. | $393.14 | 2022-2025 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $326.83 | 2021-2024 | |
| Polynovo North America LLC | $321.27 | 2024-2025 | Novosorb Btm |
| Mentor Worldwide LLC | $312.71 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Kerecis Limited | $231.30 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $222.37 | 2023-2024 | |
| Integra Lifesciences Corporation | $188.02 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Avita Medical Americas, LLC | $107.98 | 2023 | Recell |
| Becton, Dickinson and Company | $45.44 | 2024 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karina Condez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.